Shweta Singh

Title: Shweta Singh: Innovator in Antibody Conjugation Technologies

Introduction

Shweta Singh is a prominent inventor based in Fremont, CA, known for her significant contributions to the field of biotechnology. With a total of eight patents to her name, she has made remarkable advancements in the development of antibody conjugation technologies. Her work focuses on enhancing therapeutic and diagnostic applications through innovative methods.

Latest Patents

Among her latest patents, one notable invention is titled "Compositions and methods for conjugating activatable antibodies." This invention relates to the compositions and methods for conjugating antibodies and activatable antibodies, including methods for partially reducing these antibodies prior to conjugation. The techniques involve thiol-based conjugation with therapeutic and diagnostic agents. Another significant patent is "Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof." This invention encompasses antibodies that bind to CD166, as well as activatable antibodies that specifically target CD166, detailing methods for their production and application in various therapeutic, diagnostic, and prophylactic contexts.

Career Highlights

Shweta has worked with notable companies in the biotechnology sector, including CytomX Therapeutics, Inc. and Compugen Ltd. Corporation. Her experience in these organizations has allowed her to refine her expertise in antibody technologies and contribute to groundbreaking research.

Collaborations

Throughout her career, Shweta has collaborated with esteemed colleagues such as Luc Roland Desnoyers and Jason Gary Sagert. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Shweta Singh's contributions to the field of antibody conjugation technologies exemplify her dedication to advancing biotechnology. Her innovative patents and collaborative efforts position her as a leading figure in the industry.